Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and butorphanol for postoperative analgesia after microvascular decompression in trigeminal neuralgia
ChiCTR1800018946Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Nov 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, butorphanol and sufentanil in postoperative pain (4 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Postoperative pain. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
dexmedetomidinebutorphanolsufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1800018946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018946.